Screener/Mercato/ALNY

ALNY

SELL

Alnylam Pharmaceuticals, Inc.· Healthcare

Market Cap: $30.1B

Score
15
15

ANDAMENTO PREZZO

$225.10-10.37%

Prezzi aggiornati al 21 ott 2026

INDICATORI TECNICI

RSI (14 giorni)

45Debole
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)

MACD (12,26,9)

↑ RialzistaMACD -4.109 · Signal -4.451 · Hist 0.342

Prezzo vs Medie Mobili

SMA 20
$233.42+20.3%
SMA 50
$239.05+17.4%
SMA 200
$291.76-3.8%
Bollinger Band %B100% — Vicino upper band
$209mid $233$258
Volume ratio (vs media 20gg)0.95x

BREAKDOWN SCORE (0 → 100)

P/E Trailing0.0 / 25
FCF Yield6.1 / 25
Price/Book0.0 / 15
EPS8.9 / 15
Debt/Equity0.0 / 10
Dividendo0.0 / 5
Momentum 90gg0.0 / 5

FONDAMENTALI

Clicca i per spiegazione✓ 2 ok~ attenzione✗ 4 negativi
✗P/E Trailing
38.0x
~P/E Forward
18.2x
✗P/B
22.2x
✗FCF Yield
1.5%
✓EPS TTM
5,93
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
66.9%
✗Debt/Equity
2.2x
Market Cap
$30.1B
Div. Yield
0.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare

Aggiornato: 22 ott 2026